Sue K Cammarata

5PUBLICATIONS
6CO-AUTHORS
Medical infection agents (incl. prions)PharmacogenomicsPharmaceutical delivery technologiesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 10, 2025
Modeling the Impact of Antimicrobial Resistance on Medical Preparedness and Response for a Nuclear or Radiological Public Health Emergency.

Andrew J Phipps, Sue K Cammarata, Julia A Falvey

|Jun 25, 2025
Landscape of Post-Marketing Requirements Under the Pediatric Research Equity Act for Antibiotics from 2009-2024.

Daniel Selig, Funmi Aminu, Sue Cammarata

|Jan 29, 2020
A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP).

Juan P Horcajada, Robert A Salata, Rodolfo Álvarez-Sala

|Oct 24, 2018
Safety of Delafloxacin: Focus on Adverse Events of Special Interest.

Thomas Lodise, Ralph Corey, David Hooper

|May 04, 2018
Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin.

R S Dawe, J Ferguson, S Ibbotson

Pageof 1